Abstract: The invention relates to novel compounds of formula (I) and their use in the treatment of the animal or human body, to pharmaceutical compositions comprising a compound of formula (I) and to the use of a compound of formula (I) for the preparation of pharmaceutical compositions for use in the treatment of protein kinase dependent diseases, especially of proliferative diseases, such as in particular tumor diseases.
Type:
Grant
Filed:
March 13, 2007
Date of Patent:
March 13, 2012
Assignee:
Novartis AG
Inventors:
Guido Bold, Andrea Vaupel, Carole Pissot Soldermann, Paul W Manley